Production (Stage)
Cryo-Cell International, Inc.
CCEL
$4.83
$0.030.63%
AMEX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.14% | 83.36% | 54.53% | 196.74% | -27.46% |
| Total Depreciation and Amortization | 110.92% | -17.20% | -20.83% | -56.28% | -64.12% |
| Total Amortization of Deferred Charges | -1.89% | -1.85% | -1.85% | -1.85% | -1.85% |
| Total Other Non-Cash Items | 66.07% | -98.25% | -102.36% | -38.88% | 6.55% |
| Change in Net Operating Assets | 80.98% | -22.60% | 74.46% | -24.54% | -1,829.77% |
| Cash from Operations | 367.33% | -35.50% | 25.48% | -10.84% | -121.71% |
| Capital Expenditure | 86.43% | 99.52% | 94.36% | -20.21% | -21.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -293.14% | -315.19% | -403.57% | -753.36% | 114.12% |
| Cash from Investing | 15.69% | 43.70% | 80.34% | -74.90% | 71.63% |
| Total Debt Issued | 194.74% | -- | -100.00% | -- | -- |
| Total Debt Repaid | -641.13% | 51.15% | -5,154.15% | 20.63% | 54.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -115.79% | -125.62% | 29.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 437.78% | -- |
| Cash from Financing | -286.35% | 56.01% | -326.08% | 281.42% | 169.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.45% | 304.33% | 49.67% | 189.16% | 51.95% |